supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“On pair-wise analysis, lamivudine (OR 0.15, 95% CI 0.09–0.25, I -squared = 0%), telbivudine (OR 0.07, 95% CI 0.05–0.10, I -squared = 0%) and tenofovir (OR 0.07, 95% CI 0.04–0.13, I -squared = 0%) significantly decreased the MTCT rate.”
Efficacy of oral antiviral drugs to prevent mother-to-child transmission of hepatitis B virus: a network meta-analysis
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback